Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy [10] (multiple letters)

Diabetes Care

Volumn 22, Issue 6, 1999, Pages 1006-1008

  Navarro, J E ^a   Mora, C ^a   Gorson, D M ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PENTOXIFYLLINE; RENIN; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; HUMAN; LETTER; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ALBUMINURIA; DIABETIC NEPHROPATHIES; HUMANS; PENTOXIFYLLINE; PROTEINURIA; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 0032969882     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.6.1006     Document Type: Letter

References (0)